• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: ACTRIMS Forum 2026

Treatment initiation with ofatumumab: ACTRIMS Forum 2026 highlights

February 19, 2026  

ACTRIMS FORUM 2026 HIGHLIGHTS – TUESDAY, FEBRUARY 10, 2026

February 10, 2026  

ACTRIMS FORUM 2026 HIGHLIGHTS – MONDAY, FEBRUARY 9, 2026

February 9, 2026  

ACTRIMS Forum 2026 survey

February 3, 2026  

Browse by Topic

  • MSToronto2026 (6)
  • MS (450)
  • CLINICAL CASES (22)
  • EAN 2026 (2)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • AES 2025 (1)
  • EPILEPSY (38)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • MSToronto 2026 Highlights – Friday, October 23, 2026 posted on October 23, 2026
  • MSToronto 2026 Highlights – Thursday, October 22, 2026 posted on October 22, 2026
  • New ECTRIMS/EAN recommendations for vaccination in MS patients posted on September 5, 2023
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions